Infections and Cancer Epidemiology Group
The Infections and Cancer Epidemiology Group (ICE) has estimated that approximately 2 million cancer cases worldwide are attributable to infectious agents (ranging from <4% in Australia and the USA to 33% in sub-Saharan Africa). Promoting human papillomavirus (HPV) vaccination and cervical screening programmes for the prevention of cervical cancer (527 000 new cases per year worldwide) is an ICE priority. However, other associations between infectious agents and cancer require additional research and better standardized control measures. As persistent infection with viruses, bacteria, or parasites is a predominant cause of human cancer, notably in low- and middle-income countries, ICE contributes substantially to IARC′s mission of cancer prevention in the most vulnerable populations. ICE has also been active in collaborations within IARC, especially with the Infections and Cancer Biology Group (ICB), and in numerous international collaborations, notably with the United States National Cancer Institute; Free University Amsterdam, The Netherlands; Oxford University, United Kingdom; and Aviano Cancer Centre, Italy.